Metabolic biomarker signature for predicting the effect of neoadjuvant chemotherapy of breast cancer

BACKGROUND: The effect of breast cancer neoadjuvant chemotherapy (NCT) is strongly associated with breast cancer long term survival, especially when patients get a pathological complete response (PCR). It always is still unknown which patient is the potential one to get a PCR in the NCT. Thus, we ha...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Transl Med
Päätekijät: Lin, Xiaojie, Xu, Rui, Mao, Siying, Zhang, Yuzhu, Dai, Yan, Guo, Qianqian, Song, Xue, Zhang, Qingling, Li, Li, Chen, Qianjun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944618/
https://ncbi.nlm.nih.gov/pubmed/31930071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.10.34
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia